NSC 36330; 4-Methyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one; 4-methyl-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one; 2-methyl-1,2,3,5-tetrahydro-1,5-benzodiazepin-4-one; MLS002607962; CPI098; CHEMBL2142704; NSC36330; 4-Methyl-1,3,4,5-tetrahydro-benzo[b][1,4]diazepin-2-one; 4-Methyl-1,3,4,5-tetrahydro-2H-benzo[b][1,4]diazepin-2-one; F0266-2229; 4-methyl-1H,3H,4H,5H-benzo[b]1,4-diazaperhydroepin-2-one; BRN 0166063; Maybridge1_000473; Oprea1_799819; SCHEMBL4902318; CTK4I1713; HMS542N11; HMS3080B19; ALBB-017639; 1H-1,5-BENZODIAZEPIN-2-ONE, 2,3,4,5-TETRAHYDRO-4-METHYL-; BDBM50178217; MFCD00024148; NSC-36330; SBB039215; STK866163; AKOS000272070; AKOS016039074; MCULE-3074358862; MS-2384; KS-0000284A; SMR001335214; DB-049463; BB 0219744; FT-0635078; ST50112412; Y8991; EN300-09458; L-4033; 5-24-02-00516 (Beilstein Handbook Reference); AE-473/30685015; SR-01000394501; J-515749; SR-01000394501-1; W-204277; 2,3,4,5-Tetrahydro-4-methyl-1H-1,5-benzodiazepin-2-one; 4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2one; 2H-1,5-Benzodiazepin-2-one, 1,3,4,5-tetrahydro-4-methyl-; 2H-1,5-Benzodiazepin-2-one,1,3,4,5-tetrahydro-4-methyl-